Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs

Submitted by admin on January 6, 2022 - 12:36pm
Source: 
Fierce Biotech
News Tags: 
Amgen
Generate Biomedicines
biobucks
drug development
drug discovery
artificial intelligence
Headline: 
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
snippet: 

Amgen wants its future drugs to be multispecific, and so the biopharmaceutical company selected Generate Biomedicines for a $1.9 billion biobucks deal to initially create five programs across several diseases.

Do Not Allow Advertisers to Use My Personal information